People · Operator
Named in public records as an officer, director or promoter · active 2003–2025 · Pharmaceuticals, Other Health Care, Biotechnology, Healthtech, Proptech / Real Estate, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Melinta Therapeutics, Inc. /New/ | — | Pharmaceuticals | Series D+ | $346.8M | $4.9B | 2009 |
| Venus Concept Inc. | — | Other Health Care | Series C | $194.2M | $9.8M | 2019 |
| Avedro Inc | — | Other Health Care | Series C | $158.4M | $571.6M | 2018 |
| Ocugen, Inc. | — | Biotechnology | Series B | $145.6M | $566.9M | 2012 |
| Trice Medical, Inc. | — | Healthtech | Series C | $124.2M | $115.8M | 2014 |
| Nomad Health, Inc. | — | Healthtech | Series B | $106.9M | $153.2M | 2025 |
| Alcresta Therapeutics, Inc. | — | Biotechnology | Series C | $75.9M | $409.6M | 2017 |
| Venus Concept Ltd. | — | Other Health Care | Series B | $66.5M | $311.3M | 2017 |
| Castle Biosciences Inc | — | Biotechnology | Series A | $59.0M | $361.5M | 2015 |
| Ajax Health II LLC | — | Healthtech | Series C | $51.0M | $1.3B | 2019 |
| Applied Genetic Technologies Corp | — | Biotechnology | Series B | $42.9M | $340.5M | 2003 |
| Viamet Pharmaceuticals Inc | — | Pharmaceuticals | Series B | $35.0M | $850.1M | 2009 |
| Home Hospital Newco, Inc. | — | Proptech / Real Estate | Series B | $32.2M | $171.8M | 2023 |
| First Aid Beverages, Inc. | — | Other | Series B | $27.4M | $337.8M | 2015 |
| Ajax Health III LLC | — | Healthtech | Series A | $10.1M | $228.5M | 2019 |
| CancerGuide Diagnostics, Inc. | — | Biotechnology | Seed | $4.7M | $122.1M | 2010 |
Garheng Kong at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Garheng Kong on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Johnson | 2 | 25 |
| Brian Chee | 2 | 10 |
| Douglas Koo | 2 | 7 |
| William Kelley | 2 | 6 |
| Douglas Rohlen | 2 | 5 |
| Scott Barry | 2 | 4 |
| Anthony Natale | 2 | 4 |
| Domenic Serafino | 2 | 3 |
| Domenic Della Penna | 2 | 2 |
| Anna Georgiadis | 2 | 2 |
| Melissa Kang | 2 | 2 |
| Yoni Iger | 2 | 2 |
| Domenic Di Sisto | 2 | 2 |
| Fritz LaPorte | 2 | 2 |
| David J. Gill | 2 | 2 |
| Louise Lacchin | 2 | 2 |
| David King | 1 | 16 |
| Michael Greeley | 1 | 15 |
| Craig Taylor | 1 | 13 |
| Michael Lewis | 1 | 12 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.